Epigenetic regulation of organic anion transporting polypeptide 1B3 in cancer cell lines. 2013

Satoki Imai, and Ryota Kikuchi, and Yuri Tsuruya, and Sotaro Naoi, and Sho Nishida, and Hiroyuki Kusuhara, and Yuichi Sugiyama
Laboratory of Molecular Pharmacokinetics Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.

OBJECTIVE The expression of a multispecific organic anion transporter, OATP1B3/SLCO1B3, is associated with clinical prognosis and survival of cancer cells. The aims of present study were to investigate the involvement of epigenetic regulation in mRNA expression of a cancer-type variant of OATP1B3 (Ct-OATP1B3) in cancer cell lines. METHODS The membrane localization and transport functions of Ct-OATP1B3 were investigated in HEK293 cells transiently expressing Ct-OATP1B3. DNA methylation profiles around the transcriptional start site of Ct-OATP1B3 in cancer cell lines were determined. The effects of a DNA methyltransferase inhibitor and siRNA knockdown of methyl-DNA binding proteins (MBDs) on the expression of Ct-OATP1B3 mRNA were investigated. RESULTS 5'-RACE identified the TSS of Ct-OATP1B3 in PK-8 cells. Ct-OATP1B3 was localized on the plasma membrane, and showed the transport activities of E217βG, fluvastatin, rifampicin, and Gd-EOB-DTPA. The CpG dinucleotides were hypomethylated in Ct-OATP1B3-positive cell lines (DLD-1, TFK-1, PK-8, and PK-45P) but were hypermethylated in Ct-OATP1B3-negative cell lines (HepG2 and Caco-2). Treatment with a DNA methyltransferase inhibitor and siRNA knockdown of MBD2 significantly increased the expression of Ct-OATP1B3 mRNA in HepG2 and Caco-2. CONCLUSIONS Ct-OATP1B3 is capable of transporting its substrates into cancer cells. Its mRNA expression is regulated by DNA methylation-dependent gene silencing involving MBD2.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074542 Solute Carrier Organic Anion Transporter Family Member 1B3 A sodium-independent organic anion transporter that functions in the uptake of various drugs and endogenous compounds including ESTRADIOL; TAUROCHOLATE; LEUKOTRIENE C4; and METHOTREXATE. It also functions in clearing BILE ACIDS and organic anions from the liver. Mutations in the SLCO1B3 gene are associated with Rotor Type HYPERBILIRUBINEMIA. Liver-Specific Organic Anion Transporter-2,OATP1B3 Protein,OATP8 Protein,SLC21A8 Protein,SLCO1B3 Protein,Solute Carrier Family 21 Member 8 Protein,Liver Specific Organic Anion Transporter 2
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D044127 Epigenesis, Genetic A genetic process by which the adult organism is realized via mechanisms that lead to the restriction in the possible fates of cells, eventually leading to their differentiated state. Mechanisms involved cause heritable changes to cells without changes to DNA sequence such as DNA METHYLATION; HISTONE modification; DNA REPLICATION TIMING; NUCLEOSOME positioning; and heterochromatization which result in selective gene expression or repression. Epigenetic Processes,Epigenetic Process,Epigenetics Processes,Genetic Epigenesis,Process, Epigenetic,Processes, Epigenetic,Processes, Epigenetics
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D019175 DNA Methylation Addition of methyl groups to DNA. DNA methyltransferases (DNA methylases) perform this reaction using S-ADENOSYLMETHIONINE as the methyl group donor. DNA Methylations,Methylation, DNA,Methylations, DNA

Related Publications

Satoki Imai, and Ryota Kikuchi, and Yuri Tsuruya, and Sotaro Naoi, and Sho Nishida, and Hiroyuki Kusuhara, and Yuichi Sugiyama
November 2011, Yao xue xue bao = Acta pharmaceutica Sinica,
Satoki Imai, and Ryota Kikuchi, and Yuri Tsuruya, and Sotaro Naoi, and Sho Nishida, and Hiroyuki Kusuhara, and Yuichi Sugiyama
January 2017, PloS one,
Satoki Imai, and Ryota Kikuchi, and Yuri Tsuruya, and Sotaro Naoi, and Sho Nishida, and Hiroyuki Kusuhara, and Yuichi Sugiyama
June 2022, Molecular pharmacology,
Satoki Imai, and Ryota Kikuchi, and Yuri Tsuruya, and Sotaro Naoi, and Sho Nishida, and Hiroyuki Kusuhara, and Yuichi Sugiyama
June 2020, Korean journal of radiology,
Satoki Imai, and Ryota Kikuchi, and Yuri Tsuruya, and Sotaro Naoi, and Sho Nishida, and Hiroyuki Kusuhara, and Yuichi Sugiyama
October 2010, The Journal of steroid biochemistry and molecular biology,
Satoki Imai, and Ryota Kikuchi, and Yuri Tsuruya, and Sotaro Naoi, and Sho Nishida, and Hiroyuki Kusuhara, and Yuichi Sugiyama
May 2024, Toxicology in vitro : an international journal published in association with BIBRA,
Satoki Imai, and Ryota Kikuchi, and Yuri Tsuruya, and Sotaro Naoi, and Sho Nishida, and Hiroyuki Kusuhara, and Yuichi Sugiyama
June 2020, World journal of surgical oncology,
Satoki Imai, and Ryota Kikuchi, and Yuri Tsuruya, and Sotaro Naoi, and Sho Nishida, and Hiroyuki Kusuhara, and Yuichi Sugiyama
March 2011, Pharmacogenetics and genomics,
Satoki Imai, and Ryota Kikuchi, and Yuri Tsuruya, and Sotaro Naoi, and Sho Nishida, and Hiroyuki Kusuhara, and Yuichi Sugiyama
September 2011, Molecular pharmacology,
Satoki Imai, and Ryota Kikuchi, and Yuri Tsuruya, and Sotaro Naoi, and Sho Nishida, and Hiroyuki Kusuhara, and Yuichi Sugiyama
January 2014, Clinical and translational medicine,
Copied contents to your clipboard!